Scientific overview
GLP-3 is the GNW catalog name for a synthetic triple-receptor agonist research peptide. This class is characterized by activity at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Its three-receptor profile provides a basis for laboratory studies of receptor activation, intracellular signaling, and metabolic pathway interactions. The catalog designation GLP-3 describes this triple-agonist profile; it is not the name of a separate GLP-3 hormone.
Specifications
| Catalog designation | GLP-3 / Triple Agonist |
|---|---|
| Vial content | 10 mg, 15 mg, or 30 mg — select vial amount |
| Form | Lyophilized powder |
| Research focus | GIP, GLP-1, and glucagon receptor signaling |
Documentation
Certificate of Analysis (COA): In process. Batch-specific documentation will be added when available.
Research use only
For laboratory research and analytical use only. Not for human or veterinary use, consumption, or administration. This material is not a medicine and is not offered to diagnose, treat, cure, or prevent disease.
Reviews
There are no reviews yet.